Fig. 4From: Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysisOdds ratio (OR) of Lgr5 overexpression associated with clinicopathological features of colorectal cancer. a The pooled OR and its corresponding 95 % CI of Lgr5 overexpression with AJCC stage. b The pooled OR and its corresponding 95 % CI of Lgr5 overexpression with primary tumor. c The pooled OR and its corresponding 95 % CI of Lgr5 overexpression with lymph node metastasis. d The pooled OR and its corresponding 95 % CI of Lgr5 overexpression with distant metastasisBack to article page